Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
Main Authors: | Doyle Mark, Pohost Gerald M, Shaw Leslee J, Vido Diane A, Kelsey Sheryl F, Johnson BD, Rogers William J, Rayarao Geetha, Sharaf Barry L, Pepine Carl J, Merz Noel B, Biederman Robert W |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Journal of Cardiovascular Magnetic Resonance |
Similar Items
-
Decisions Informed by Computing Entities (DICE) to improve prognostic value of myocardial perfusion imaging: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
by: Doyle Mark, et al.
Published: (2012-02-01) -
Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study
by: Pepine Carl J, et al.
Published: (2011-02-01) -
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
by: John W Petersen, et al.
Published: (2014-01-01) -
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
by: Ahmed AlBadri, et al.
Published: (2017-01-01) -
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
by: Sharaf Barry L, et al.
Published: (2008-03-01)